Search
for
Sort by
Research 361–390 of 735
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- A bibliometric analysis of T cell and atherosclerosis
- New and Emerging Therapies for Alopecia Areata
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Multifunctional antibacterial bioactive nanoglass hydrogel for normal and MRSA infected wound repair
- Dupilumab side effect in a patient with atopic dermatitis: a case report study
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Therapeutic Values of Exosomes in Cosmetics, Skin Care, Tissue Regeneration, and Dermatological Diseases
- Immune therapies for alopecia areata: evidence and new perspectives
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Spatiotemporal immunomodulation by engineered hair follicle stem cell-derived nanovesicles enables scarless regeneration of infected wounds
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Editor's Picks August 2023
- 599 Amelioration of symptoms of dry and eczema-prone skin by an oil-in-water emulsion containing a combination of a zingiber officinale root extract and cbd with antioxidative and anti-inflammatory activity in vitro
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria
- Decreased GATA3 levels cause changed mouse cutaneous innate lymphoid cell fate, facilitating hair follicle recycling
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Interleukin gene polymorphisms and alopecia areata: A systematic review and meta-analysis
- Alopecia Areata
- Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Emerging Topical and Systemic JAK Inhibitors in Dermatology